Recognized foreign exchange gains in the second quarter of the fiscal year ending March 2027 and upwardly revised the full-year forecast. Revenue increased by 6,300 million yen from the previous forecast, operating income increased by 6,000 million yen, and profit attributable to owners of parent was revised up by 2,600 million yen. Foreign exchange assumptions were changed from EUR 1 = 165 yen to 182 yen and USD 1 = 145 yen to 159 yen. By segment, Diabetes Management and Diagnostics & Life Sciences were revised upward, while Healthcare Solutions was revised downward.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6523","jir_company_name":"PHC Holdings Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/6523-20261111-02.pdf","jir_short_summary":"Recognized foreign exchange gains in the second quarter of the fiscal year ending March 2027 and upwardly revised the full-year forecast. Revenue increased by 6,300 million yen from the previous forecast, operating income increased by 6,000 million yen, and profit attributable to owners of parent was revised up by 2,600 million yen. Foreign exchange assumptions were changed from EUR 1 = 165 yen to 182 yen and USD 1 = 145 yen to 159 yen. By segment, Diabetes Management and Diagnostics & Life Sciences were revised upward, while Healthcare Solutions was revised downward.","jir_summary":"### Performance Overview\nThis document announces the recognition of foreign exchange gains in the second quarter of the fiscal year ending March 2027 and the revision of the full-year earnings forecast. Due to the recognition of foreign exchange gains, the full-year outlook for revenue, operating income, profit before tax, net income and adjusted EBITDA has been revised upward. Foreign exchange assumptions were changed from EUR 1 = 165 yen to 182 yen and USD 1 = 145 yen to 159 yen. The revisions incorporate upside in Diabetes Management and Life Sciences businesses, while reflecting some impact on Healthcare Solutions.\n\n### Segment Impact and Outlook\nDiabetes Management was revised upward for both revenue and profit. Diagnostics & Life Sciences was revised upward reflecting market recovery and foreign exchange benefits. Conversely, Healthcare Solutions was revised downward reflecting a reduction in electronic medical record sales due to server supply constraints. At the company level, the contribution of foreign exchange gains and revisions to raw material costs and SG&A have increased the full-year outlook for key metrics.","jir_financial_highlights":"Revenue: Previous forecast 359,700 million yen \u2192 Current forecast 366,000 million yen (Increase 6,300 million yen)\nOperating Income: Previous forecast 27,000 million yen \u2192 Current forecast 33,000 million yen (Increase 6,000 million yen)\nProfit before Tax: Previous forecast 22,000 million yen \u2192 Current forecast 26,700 million yen (Increase 4,700 million yen)\nNet Income Attributable to Owners of Parent: Previous forecast 15,400 million yen \u2192 Current forecast 18,000 million yen (Increase 2,600 million yen)\nAdjusted EBITDA: Previous forecast 53,600 million yen \u2192 Current forecast 60,900 million yen (Increase 7,300 million yen)","jir_category":"","jir_hashtags":"#PHCHOLDINGS, #RecognitionOfForeignExchangeGain, #EarningsReport, #FullYearRevision","jir_key_figures":"Previous forecast Revenue: 359,700 million yen\nCurrent forecast Revenue: 366,000 million yen\nPrevious forecast Operating Income: 27,000 million yen\nCurrent forecast Operating Income: 33,000 million yen\nPrevious forecast Net Income Attributable to Owners of Parent: 15,400 million yen\nCurrent forecast Net Income Attributable to Owners of Parent: 18,000 million yen","jir_meta_title":"PHC Holdings Corporation \u2014 Recognition of Financial Income and Revision of Full-Year Forecast | Q2 FY2027","jir_meta_description":"PHC Holdings Corporation recognized foreign exchange gains in Q2 FY2027 and upwardly revised its full-year forecast. Details on segment impacts, revised FX assumptions and drivers of increases in key metrics are provided.","jir_og_title":"PHC Holdings Corporation | Recognition of Financial Income and Revision of Full-Year Forecast","jir_og_description":"PHC Holdings Corporation announced recognition of foreign exchange gains and revisions to the full-year forecast. Explains drivers of increases in key metrics and segment impacts.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9274,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-149258","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n